Kisho

MSD International Business GmbH — Rare Disease Pipeline | Kisho | Kisho

MSD International Business GmbH

Other

Orphan Designations

FDA Approvals

Rare Diseases

News Articles

Disease	Drug(s)	Designation	Approved
Bicervical bicornuate uterus with patent cervix and vagina	Keytruda	Orphan Designation	-
Char syndrome	Keytruda	Orphan Designation	-
Cryoglobulinemic vasculitis	Keytruda	Orphan Designation	-
Hodgkins lymphoma	Keytruda	Orphan Designation	-
MALT lymphoma	Keytruda	Orphan Designation	-
adult embryonal tumor with multilayered rosettes, c19mc-altered	Keytruda	Orphan Designation	-
adult hepatocellular carcinoma	Keytruda	Orphan Designation	-
adult neuronal ceroid lipofuscinosis	Keytruda	Orphan Designation	-
adult pleomorphic rhabdomyosarcoma	Keytruda	Orphan Designation	-
adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy	Keytruda	Orphan Designation	-
adult-onset non-insulinoma persistent hyperinsulinemic hypoglycemia	Keytruda	Orphan Designation	-
adult-onset proximal spinal muscular atrophy, autosomal dominant	Keytruda	Orphan Designation	-
carbon monoxide-induced delayed encephalopathy	Keytruda	Orphan Designation	-
carcinoma of esophagus	Keytruda	Orphan Designation	-
cataract 13 with adult I phenotype	Keytruda	Orphan Designation	-
deafness, congenital, and adult-onset progressive leukoencephalopathy	Keytruda	Orphan Designation	-
distal biliary tract carcinoma	Keytruda	Orphan Designation	-
fibrolamellar hepatocellular carcinoma	Keytruda	Orphan Designation	-
gastric cancer	Keytruda	Orphan Designation	-
hepatocellular carcinoma	Keytruda	Orphan Designation	-
hepatocellular clear cell carcinoma	Keytruda	Orphan Designation	-
malignant carotid body paraganglioma	Keytruda	Orphan Designation	-
mediastinal malignant lymphoma	Keytruda	Orphan Designation	-
multisystemic smooth muscle dysfunction syndrome	Keytruda	Orphan Designation	-
nasopharyngeal carcinoma	pembrolizumab	Orphan Designation	-
natal teeth-intestinal pseudoobstruction-patent ductus syndrome	Keytruda	Orphan Designation	-
nut midline carcinoma	Keytruda	Orphan Designation	-
pediatric acute-onset neuropsychiatric syndrome	Keytruda	Orphan Designation	-
pediatric hepatocellular carcinoma	Keytruda	Orphan Designation	-
pediatric ovarian dysgerminoma	Keytruda	Orphan Designation	-
pediatric ovarian germ cell tumor	Keytruda	Orphan Designation	-
pediatric-onset Graves disease	Keytruda	Orphan Designation	-
post-treatment Lyme disease syndrome	Keytruda	Orphan Designation	-
primary adult heart tumor	Keytruda	Orphan Designation	-
primary mediastinal large B-cell lymphoma	Keytruda	Orphan Designation	-
small cell lung carcinoma	Keytruda	Orphan Designation	-
squamous carcinoma in situ	Keytruda	Orphan Designation	-
stage II endometrioid carcinoma	Keytruda	Orphan Designation	-
stage IVb bladder cancer	Keytruda	Orphan Designation	-
thymic neuroendocrine tumor	Keytruda	Orphan Designation	-
trabecular adenocarcinoma	Keytruda	Orphan Designation	-
treatment-refractory schizophrenia	Keytruda	Orphan Designation	-
uterine cervix carcinoma in situ	Keytruda	Orphan Designation	-

← Back to Companies